Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 5, 2002, Pages 1320-1329

  Rovirosa, Angeles ^a   Ascaso, Carlos ^a   Ordi, Jaume ^a   Abellana, Rosa ^a   Arenas, Meritxell ^a   Lejarcegui, José Antonio ^a   Pahisa, Jaume ^a   Puig Tintoré, Luis M ^a   Mellado, Begoa ^a   Armenteros, Beatríz ^a   Iglesias, Xavier ^a   Biete, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Prognostic factors; Radiotherapy; Uterine sarcomas; Vascular and lymphatic space invasion

Indexed keywords

CHEMOTHERAPY; PATIENT MONITORING; SURGERY; TUMORS;

MULTIVARIATE ANALYSIS; SARCOMATOUS NEOPLASMS;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; COBALT 60;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; UTERUS SARCOMA;

ADENOSARCOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 0036534864     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02808-5     Document Type: Article

References (70)

1. Sarcomas uterinos; Un reto para el oncólogo
2. Effects of irradiation on mixed müllerian tumors of the uterus
3. Uterine sarcomas; An analysis of 69 patients
4. The role of radiation therapy in the management of uterine sarcomas
5. Uterine sarcomas. Natural history, treatment and prognosis
6. Uterine sarcomas; Incidence and trends in management and survival
7. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994
8. Uterine sarcoma in the south of Israel; Study of 36 cases
9. Prognostic factors in uterine sarcomas; Retrospective study of 21 years at the Hospital Clínica i Provincial de Barcelona
10. Patterns of recurrence in malignant mixed müllerian tumor of the uterus
11. Uterine sarcomas
12. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri
13. Impact of radiotherapy on local control and survival in uterine sarcomas; A retrospective study from the Grup Oncologic Catala-Occita
14. Sarcomas of the uterus; A clinicopathologic study of 119 patients
15. Treatment, results, and prognosis factors in stage I and II sarcomas of the corpus uteri
16. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors; The result of a retrospective study of 423 cases of uterine sarcoma
17. Uterine sarcomas; Prognostic factors and treatment modalities-study on 209 patients
18. Uterine leiomyosarcoma; Analysis of treatment failures and survival
19. Clinicopathologic analyses of uterine malignant mixed müllerian tumors
20. Uterine sarcomas; The curie institut experience. Prognosis factors and adjuvant treatments
21. Uterine sarcomas; A clinicopathological study
22. A randomized clinical trial of adjuvant adriamicin in uterine sarcomas; A Gynecologic Oncology Group study
23. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas
24. Adjuvant therapy in mixed mullerian tumors of the uterus
25. Uterine sarcomas in Israel; A study of 104 cases
26. Malignant mixed müllerian tumors of the uterus
27. The value of radiation therapy in uterine sarcoma
28. Chemotherapy for advanced sarcoma; Therapeutic decisions and modalities
29. Treatment of stage IV 'high-grade' endometrial stromal sarcoma with ifosfamide, adriamycin and cisplatin
30. Management of malignant mixed mesodermal tumors of the uterus
31. Uterine sarcomas; A clinicopathologic study, 1965-1981
32. Gynecol Oncol Group studies with ifosfamide
33. Tratamiento radiológico de los sarcomas uterinos. Analisis retrospectivo
34. Leiomyosarcoma of the uterus
35. Prognostic factors in uterine carcinosarcoma. A clinicopathologic study of 25 patients
36. Uterine sarcomas
37. Stage I endometrial carcinoma; The importance of pathologic review in retrospective analyses
38. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study
39. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases
40. Tumors of the uterine corpus and gestational trophoblastic disease
41. Endometrium
42. Uterine sarcomas and related tumors
43. Retrospective analysis of 318 cases of uterine sarcoma
44. Mesenchymal tumors of the uterus. A clinical and pathologic study of 31 mixed mesodermal tumors
45. The prognostic significance of vascular invasion by endometrial carcinoma
46. Recurrent carcinoma of the endometrium; A clinical and pathological study of 379 patients
47. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus
48. Lymph-vascular space involvement-a prognostic indicator in endometrial adenocarcinoma
49. Aggressive stage I and grade I endometrial carcinoma
50. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma
51. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer
52. The significance of vascular invasion and lymphocitic infiltration in invasive cervical cancer
53. Vascular invasion as a prognostic factor in stage Ib cancer of the cervix
54. The clinical significance of invasion veins by rectal cancer
55. Operative management of early invasive epidermoid carcinoma of the vulva
56. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected non small cell carcinoma of the lung with pulmonary metastases
57. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0M0)
58. Surgical pathologic spread patterns of endometrial cancer (a GOG study)
59. Mixed mesodermal sarcoma of the uterus
60. Uterine sarcoma; An analysis of 74 cases
61. A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas
62. Treatment of uterine sarcomas
63. Assessing the impact of adjuvant pelvic radiotherapy for uterine sarcomas
64. Uterine sarcoma; Analysis of prognostic variables in 71 cases
65. Adjuvant vincristine, dactinomycin and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study
66. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma